Dr. Hajime Takashima is responsible for all aspects of chemistry and medicinal chemistry in PRISM BioLab. In addition to managing and promoting pipeline projects and collaboration projects with our partners, he oversees in silico drug design, compound management, and intellectual property management. His specialties are medicinal chemistry, organic chemistry, and computational chemistry. Before joinning in...

Dr. Tatsuya Toma is responsible for synthesis and scaffold development as well as medicinal chemistry in PRISM BioLab. Before joining in PRISM BioLab, he had an academic career as an assistant professor at Nagoya University. His research involves total synthesis of complex natural products as well as chemical biology. He received his undergraduate and PhD...

Masataka Umitsu is responsible for protein science and biophysics. He has experienced broad type of research programs in Japan and Toronto/Canada, and drug discovery projects in Japanese biotech, and joined to PRISM BioLab in 2024. He received his bachelor’s degree from International Christian University (ICU), master’s degree from OSAKA UNIVERSITY, and Ph.D. from the University...

Shuhei Yamakoshi is responsible for medicinal chemistry at PRISM BioLab. He has experience in small-molecule and natural product-based drug discovery targeting immunological and oncological diseases at a domestic pharmaceutical company. He contributed to the establishment of a platform for targeted protein degradation technologies. Subsequently, he worked at Japanese biotech company, where he focused on peptide...

Dr. Tomohiro Yoshida is responsible for medicinal chemistry as well as preclinical strategy in PRISM BioLab. He has more than 30 years experience in R&D, including translational research as a project leader/manager at Mitsubishi Tanabe Pharma Corp. In 2013, he earned the Breakthrough Award, Division of Medicinal Chemistry, PSJ for the discovery of an antidiabetic...